3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
50
INDUSTRY
4
NETWORK
2
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Colorectal Neoplasms
1
Interventions
fludarabine phosphate
1
fludarabine
1
daratumumab
1
carfilzomib
1
Lenalidomide
1
Dexamethasone
1
Cyclophosphamide
1
Azacitidine
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Neoplasms, Plasma Cell
×
Lenalidomide
×
Clear all
NCT04065789
2022-01-27
KyDaR
Tel-Aviv Sourasky Medical Center
Phase 2
Completed
41 enrolled